Differential retinoic acid signaling in the hippocampus of aged rats with and without memory impairment. by Wołoszynowska-Fraser, MU et al.
Copyright © 2021 Wo#oszynowska-Fraser et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution
4.0 International license, which permits unrestricted use, distribution and reproduction in any
medium provided that the original work is properly attributed.
Research Article: New Research | Cognition and Behavior
Differential retinoic acid signaling in the
hippocampus of aged rats with and without
memory impairment
https://doi.org/10.1523/ENEURO.0120-21.2021
Cite as: eNeuro 2021; 10.1523/ENEURO.0120-21.2021
Received: 22 March 2021
Revised: 9 August 2021
Accepted: 17 August 2021
This Early Release article has been peer-reviewed and accepted, but has not been through
the composition and copyediting processes. The final version may differ slightly in style or
formatting and will contain links to any extended data.
Alerts: Sign up at www.eneuro.org/alerts to receive customized email alerts when the fully
formatted version of this article is published.
   
 
 1 
Title: Differential retinoic acid signaling in the hippocampus of aged rats with and without memory 1 
impairment 2 
Abbreviated title: Retinoic acid signaling in neurocognitive aging 3 
Marta U. Wołoszynowska-Fraser1, Sharyn L. Rossi1, Jeffrey M. Long1, Peter J. McCaffery2, Peter R. Rapp1* 4 
1 Laboratory of Behavioral Neuroscience, Neurocognitive Aging Section, National Institute on Aging, Baltimore, MD 5 
21224, USA 6 
2 Institute of Medical Science, School of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, 7 
Scotland, UK 8 
 9 
* Corresponding author: 10 
Peter R. Rapp 11 
National Institute on Aging 12 
251 Bayview Blvd., Suite 100, Rm 09C224 13 
Baltimore, MD 21224 14 
 15 
Phone: 410-588-8195 16 
Email:  rappp@mail.nih.gov 17 
 18 
Number of pages: 21 19 
Number of figures: 6 20 
Number of tables: 1 21 
Word count: 22 
- Abstract - 220 23 
- Introduction - 645 24 
- Discussion - 1632 25 
 26 
Conflict of interest: P.J.M is non-executive director of Nevrargenics Ltd, a company developing synthetic retinoids 27 
for use in neurodegenerative disease. Other authors declare no conflict of interest. 28 
 29 
Acknowledgments: 30 
M.U.W.-F. is now at Keele University, England; S.L.R. is at Bright Focus Foundation. This research was supported 31 
entirely by the Intramural Research Program of the NIH, National institute on Aging. The authors thank the members 32 





  38 




Retinoic acid (RA), a metabolite of vitamin A, has many physiological functions, and mounting evidence points to 40 
important roles in cognition. In vitro experiments indicate that RA is involved in homeostatic synaptic scaling in the 41 
hippocampus, which supports overall network stability during learning. It has been previously determined that 42 
disrupted RA signaling in the hippocampus causes deterioration of memory, that RA signaling declines with age in 43 
brain, and that application of RA reverses this decline. Here we explore whether RA signaling is altered in an animal 44 
model of neurocognitive aging. We utilized a Morris water maze protocol to study cognitive decline in aged rats, 45 
which assesses hippocampus-dependent spatial memory and reveals substantial inter-individual differences in aged 46 
animals. Aged unimpaired (AU) rats perform on par with young, while aged impaired (AI) animals exhibit spatial 47 
memory deficits. We show that the major substrate for RA, retinol binding protein 4, is decreased in AU rats, and 48 
retinol cell surface receptor declines with chronological age. Other affected components of RA signaling include 49 
selective increases in AI animals in hippocampal synthesis (RALDH1) and catabolism of RA (CYP26B1), RA receptor α, 50 
the RA regulated ionotropic glutamate receptor (GluR1), as well as fragile X mental retardation protein. The results 51 
support the conclusion that, surprisingly, increased RA signaling in the aged hippocampus is associated with poor 52 
cognitive outcome.  53 
 54 
SIGNIFICANCE STATEMENT 55 
Growing evidence indicates that retinoic acid (RA) function extends well beyond metabolic control and includes the 56 
regulation of memory-related synaptic plasticity. Here we explore whether RA signaling is altered in an animal 57 
model of neurocognitive aging. We show that in fact RA function is altered at nearly all levels examined, and these 58 
results are unrelated to metabolic aging. Overall, the net effect points in the direction of increased RA signaling in 59 
impaired aged animals, which may contribute to disruption in excitation/inhibition balance, a prominent feature of 60 
age-related cognitive impairment and suspected early event in the pathogenesis of Alzheimer’s disease.  61 
 62 
 63 





Circulating levels of retinoic acid (RA), a metabolite of vitamin A (retinol), are dependent on dietary availability 66 
because animals are unable to synthesize retinol de novo. Dietary sources can be from plants in the form of 67 
carotenoids or animal sources (retinyl esters; Blomhoff & Blomhoff, 2006). RA has many physiological functions, 68 
including control of neuronal differentiation during development, and modulation of neuronal plasticity and 69 
neurogenesis in the adult hippocampus (Maden, 2007; Nomoto et al., 2012; Chen et al., 2014). A potential role in 70 
memory processes is emerging and RA supplementation as a potential intervention for successful cognitive aging 71 
has received preliminary support (Mingaud et al., 2008; Dumetz et al., 2020). Complementing these findings, retinol 72 
deficiency during adolescence causes memory impairments comparable to those seen in aged rodents, and vitamin 73 
A supplementation can reverse these deficits (Bonnet et al., 2008; Etchamendy et al., 2001). The age-related 74 
reduction of plasma retinol binding protein (Kocełak et al., 2018), and retinol (Van Der Loo et al., 2004), as well as 75 
decreased vitamin A metabolism (Touyarot et al., 2013), suggest an overall decrease in RA signaling in aging 76 
(Enderlin et al., 1997; Etchamendy et al., 2003; Das et al., 2014). A global diminishment in RA functions may link 77 
metabolic aging and neurobiological mechanisms responsible for age-associated cognitive decline. 78 
 79 
In the blood, retinol circulates freely or bound to retinol binding protein 4 (RBP4), which is carried by transthyretin 80 
(TTR). TTR allows stable transport of RBP4 bound retinol and prevents RBP4 filtration and degradation by the kidney 81 
(Kanai et al., 1968; Palha, 2002; Vieira and Saraiva, 2014). Circulating retinol enters the cell via STRA6 (STimulated by 82 
Retinoic Acid-6) receptor or, due to its lipophilic properties, via cell membrane diffusion (Napoli, 2012; O’Byrne and 83 
Blaner, 2013). Inside the cell, retinol binds to the cellular retinol binding proteins and is further metabolized to RA. 84 
The last step of RA synthesis is catalyzed by the retinaldehyde dehydrogenase enzymes (RALDHs). RA can exhibit 85 
genomic or non-genomic functions, via binding to RA receptors (RARs and RXRs), diffuse to neighboring cells, or be 86 
catabolized by the cytochrome p450 family enzymes (CYP26s)(Chen and Napoli, 2008; Chen et al., 2008; Shearer et 87 
al., 2012).  88 
 89 
The growth, development, and ability of neurons to adapt to a changing environment are crucial for normal 90 
cognition. Mounting evidence points to the involvement of RA in memory formation. RA is involved in homeostatic 91 
synaptic scaling in the hippocampus, which maintains neuronal network stability in the face of learning-induced 92 
changes in synaptic strength (Groth and Tsien, 2008). This modulation is mediated through RA binding to its 93 
receptor alpha (RARα), which acts as an RNA-binding granule (Maghsoodi et al., 2008), promoting the dissociation of 94 
ionotropic glutamate receptor (GluR1) mRNA bound to RARα, making it available for translation. The fragile X 95 
mental retardation protein (FMRP) is required for the translation of GluR1, which results in an increase of dendritic 96 
synthesis of GluR1 and synaptic strength (Aoto et al., 2008; Soden and Chen, 2010). The expression of glutamate 97 
receptors  and glutamate uptake decline with age, potentially contributing to memory decline (Segovia et al., 2001; 98 
Yang et al., 2015).  99 
 100 
To examine the link between hippocampal RA signaling and neurocognitive aging, we used a well-established animal 101 
model of age-related cognitive decline. In this model, the hippocampus in aged rats with spatial memory deficits 102 
displays a complex constellation of changes relative to younger animals and age-matched subjects with intact 103 
memory, including a decrease in the number of inhibitory somatostatin neurons in the dentate gyrus, increased 104 
basal Arc protein expression but diminished behavioral induction in the pyramidal cell fields, as well as pyramidal 105 
neuron hyperactivity in the CA3 region (Wilson et al., 2005; Spiegel et al., 2013; Fletcher et al., 2014). Here we 106 
measured plasma RBP4 and protein levels of hippocampal STRA6 receptor, RA synthesizing and catabolizing 107 
enzymes, RARα, FMRP and GluR1 in young rats and aged animals with and without memory impairment.  108 
 109 




MATERIALS and METHODS 111 
 112 
Animals 113 
Young (6 months; n=16) and aged (24 months; n=32) male Long Evans rats (Charles River Laboratories, Raleigh, NC) 114 
were single housed in a climate controlled vivarium, on a 12:12h light:dark cycle. Animals had ad libitum access to 115 
food (Teklad Global 18% protein extruded rodent diet with Vitamin A acetate, 30IU/g, 1IU=0.3g retinol) and water. 116 
Rats were screened for health conditions, including skin conditions incompatible with water maze exposure, 117 
cataracts and tumors. Only healthy animals were used.  118 
 119 
 120 
Ethical statement 121 
This study was carried out in accordance with the recommendations in the Guide for the Care and Use of Laboratory 122 
Animals of the National Institutes of Health. The protocol was approved by the Animal Care and Use Committee of 123 
the National Institute on Aging (ASP number LBN-407-2020).  124 
 125 
 126 
Spatial learning and memory/background behavioral characterization 127 
Hippocampal-dependent spatial learning and memory were assessed using a Morris water maze protocol, optimized 128 
for documenting individual differences in aging (Gallagher et al., 1993). Briefly, animals were trained to find the 129 
location of a hidden platform, 3 trials per day over 8 consecutive days. Probe trials were interpolated throughout 130 
training (one the last trial of every other day), to record spatial bias for the location of the platform. For the probes, 131 
the platform was unavailable for escape during the first 30 sec of the trial.  A Learning Index (LI) score for each 132 
animal was calculated based on average proximity (in cm) to the hidden escape location across the last three probe 133 
trials. Lower LI scores indicate better search accuracy focused on the escape location. Aged animals that performed 134 
on par with young (Y) were classified as aged unimpaired (AU), while aged animals that performed above an LI cut-135 
off based on Y were classified as aged impaired (AI). The cut off (LI of 240) is based on the normative distribution of 136 
scores for many hundreds of young rats in previous research (e.g., Gallagher et al., 1993; Rapp and Gallagher, 1996; 137 
Maei et al., 2009; Haberman et al., 2012; Tomás Pereira and Burwell, 2015).  138 
 139 
 140 
Tissue collection 141 
Euthanasia for post-mortem analysis occurred in the morning/early afternoon no sooner than 2 weeks after 142 
completing water maze training, in order to minimize the influence of behavioral testing on the RA measures of 143 
interest. Animals were disoriented or briefly anaesthetized using Isoflurane and decapitated. Trunk blood was 144 
collected in heparinized tubes, which were slowly inverted multiple times and placed on wet ice. Blood was 145 
transferred to Eppendorf tubes and spun at 1500G for 20 minutes at 4°C. Supernatant (plasma) was then 146 
transferred to a separate tube and both were kept at -80°C. Brains were extracted, and hippocampi were rapidly 147 




Retinol binding protein 4 (RBP4) enzyme-linked immune-absorbent assay (ELISA) was performed using a rat RBP4 kit 152 
(Abcam, ab203362). Plasma samples were diluted to 1 in 500,000, before performing the assay.  A standard curve 153 
was created using stock RBP supplied and results were obtained by measuring the absorption at 450nm. 154 
 155 




Plasma glucose, triglyceride and creatinine assays 157 
Plasma glucose levels were measured with an assay kit (Abcam, ab65333). Plasma samples were first deproteinized 158 
with 10kD spin columns (Abcam, ab93349). A standard curve was generated using stock glucose provided. The assay 159 
was run per manufacturer instructions and the absorption was measured at 570nm. Triglyceride content was tested 160 
using an assay kit (Biovision, #622). Manufacturer’s instructions were followed to obtain the standard curve from 161 
the triglyceride stock provided, the results were obtained by measuring the absorption at 570nm and plasma 162 
triglyceride content was calculated. An assay kit was used to determine plasma creatinine content (Biovision, #625). 163 
Deproteinized plasma samples were tested. Manufacturer instructions were followed, and stock creatinine was used 164 
to create a standard curve and absorption was read at 570nm. 165 
 166 
 167 
Protein extraction and quantification 168 
Proteins from one hippocampus per animal (young n=8, aged n=16) were extracted using tissue protein extraction 169 
reagent (T-PER™; Thermo Fisher Scientific) with HALT protease inhibitor cocktail (100x; Thermo Fisher Scientific), 170 
homogenized, sonicated, spun down for 20 min (13200rpm at 4°C) and supernatant collected. Protein content in 171 
the supernatant was measured using Pierce’s bicinchoninic acid (BCA) assay (Thermo Fisher Scientific). Proteins 172 
were made into stock solution of 5mg/ml. 173 
 174 
 175 
Synaptosome preparation 176 
Synaptic protein extraction reagent (Syn-PER™; Thermo Fisher Scientific) was used to isolate synaptosomes, which 177 
contain key pre- and postsynaptic proteins. Briefly, 10ml of Syn-PER™ was added to each mg of hippocampal tissue, 178 
which was then homogenized using Dounce homogenizer. Samples were then centrifuged at 3600rpm for 10 min at 179 
4°C. Supernatant was placed in a fresh tube and centrifuged again at 12700rpm for 20 min at 4°C. Supernatant was 180 
then removed, and the pellet resuspended in Syn-PER™ (2ml/g of tissue). Again, protein content was measured by 181 
BCA assay and made into 5mg/ml stock solution. 182 
 183 
 184 
Western Blot 185 
Samples (25mg protein per well/lane) were separated by SDS-PAGE Bis-Tris gel (Invitrogen) and MES-SDS buffer 186 
(Invitrogen). All groups (Y, AU and AI) were represented within each gel. Following separation, proteins were 187 
transferred onto PVDF membranes (Invitrogen) using an iBlot dry blotting system (Invitrogen). The antibodies were 188 
diluted in blocking solution (2% ELC advance blocking agent; GE Healthcare) in wash buffer (TBS and 0.1% Tween-189 
20) and membranes were incubated overnight at 4°C. Immunoreactivity was detected by application of conjugated 190 
secondary antibodies (AlexaFluor 488; AlexaFluor 546; CY5; Jackson ImmunoResearch Laboratories). The 191 
immunoblots were scanned on a Sapphire imager (Azure Biosystems, Inc.) at 100mm resolution and quantified using 192 
ImageJ software (National Institutes of Health, USA). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) or b-193 
actin were used as loading controls and all results were normalized to the expression of these proteins.  194 
  195 
   
 
 6 
Primary antibodies 196 
The primary antibodies and their dilutions are listed in Table 1. 197 
Antibody name Host WB dilution Predicted molecular weight Supplier Catalogue number 
Anti-RALDH1 goat 1:3000 55kDa Abcam ab9883 
Anti-RALDH3 rabbit 1:1000 57kDa Abcam ab129815 
Anti-𝛽-actin mouse 1:30 000 45kDa BioVision Incorporated 3598 








Anti-FMRP rabbit 1:1000 80kDa Abcam ab17722 















51kDa Abcam ab28767 









Statistical analysis 203 
Statistical analysis was performed using Prism 7.0 (GraphPad Software, Inc., La Jolla USA). Unless otherwise stated, 204 
unpaired 2-tailed Student’s t-test was used when comparing two groups, while 2-way analysis of variance (2-way 205 
ANOVA) with Tukey’s multiple comparison test was applied to multiple group analysis. Pearson r correlation 206 
coefficients were calculated to investigate associations between variables of interest. Values of p<0.05 were 207 
considered statistically significant. An observation was considered an outlier if its value was more than 2 standard 208 







Aged rats display increased individual differences in spatial memory  216 
Spatial memory was assessed in the Morris water maze using a protocol optimized for the study of cognitive aging 217 
(Gallagher et al., 1993). Over the course of testing rats were given probe trials to assess spatial bias for the platform 218 
location, and LI scores were calculated for each animal. As predicted, aged animals, on average displayed higher LI 219 
scores (young mean=182.3 (n=16), aged mean=239.1 (n=32), t(46)=4.537, p<0.0001; FIG. 1A). Consistent with many 220 
   
 
 7 
earlier studies (Lee et al., 2005; Castellano et al., 2012; Fletcher et al., 2014; Myrum et al., 2019), the aged group 221 
exhibited substantially increased variability such that some rats performed on par with young, while others 222 
performed well outside the normal range. Aged animals with LI scores below 240 (n=15) were classified as aged 223 
unimpaired (AU), and rats that scored above 240 (n=17) were operationally defined aged impaired (AI). This animal 224 
model provides an opportunity to test for chronological age effects (young vs. aged), while also allowing the study of 225 
mechanisms of cognitive aging, by comparing the young, AU and AI, and exploring potential linear correlations 226 
between LI scores and RA signaling factors in the same subjects. 227 
 228 
 229 
Plasma retinol-binding protein 4 is reduced in aged animals without memory impairment 230 
Retinol can circulate free in blood or bound to RBP4/TTR complex. We tested plasma RBP4 concentration, which is 231 
indicative of retinol availability. We found no differences in plasma RBP4 between the young and aged groups 232 
(t(22)=1.568, p=0.131; FIG. 1B). However, RBP4 levels were significantly lower in AU compared to Y and AI rats 233 
(F(2,21)=11.48, p=0.0004; Y vs. AU p=0.0019; AU vs. AI p=0.0009; FIG. 1C). Additionally, levels of circulating retinol-234 
binding protein strongly correlated with spatial memory performance among the aged rats such that subjects with 235 
higher RBP4 levels displayed worse spatial memory (n=16, r2=0.303, p=0.027; FIG. 1D, black line). The correlation 236 
was not significant when the data for young rats were included in the analysis (n=24, r2=0.055, p=0.273; FIG. 1D, 237 
grey line), suggesting that coupling between RBP4 availability and hippocampal memory function emerges 238 
specifically in relation to cognitive aging.  239 
 240 
Although the liver is the major peripheral source of RBP4, it is also released by adipocytes (Thompson et al., 2017), 241 
and elevated RBP4 levels have been reported in obese and diabetic individuals (Yang et al., 2005; Esteve et al., 242 
2009). Since aged rats are heavier than young adults (young mean=653g, aged mean=828g, t(22)=3.979, p=0.0006; 243 
FIG. 1E) we examined whether RBP4 levels correlate with body weight.  In the aged group there was no difference in 244 
body weight between AU and AI rats (t(14)=0.06, p=0.95; FIG. 1F). RBP4 levels were unrelated to body weight in 245 
young and aged animals considered together (n=24, r2=0.01, p=0.65; FIG. 1G, grey line), and no correlation between 246 
body weight and RBP levels was detected when AU and AI rats were considered alone (n=16, r2=0.032, p=0.032; FIG. 247 
1G, black line). These results indicate that RBP4 levels in aging are more tightly linked with individual differences in 248 
cognitive outcome than with the effects of chronological age, per se.  249 
 250 
 251 
Aged Long-Evans rats do not display metabolic syndrome 252 
Plasma glucose, triglyceride and creatinine content were measured to determine if aged animals display metabolic 253 
symptoms that might affect RBP4 levels. Plasma glucose was significantly lower in aged animals compared with 254 
young (t(22)=2.445, p=0.023; FIG. 2A). This difference was especially prominent when AI rats were compared with 255 
young (F(2,21)=4.155, p=0.03; Y vs. AI, p=0.023; FIG. 2B), but not with AU (p=0.34). Thus, despite substantially 256 
increased weight, pancreatic function seems to keep glucose levels on par with, or lower than, in young rats 257 
compared to AU and AI animals. Plasma triglyceride content was measured to test liver function, and the results 258 
showed no difference between young and aged animals (t(22)=0.319, p=0.75; FIG. 2C), or when aged rats were split 259 
depending on their cognitive profile (F(2,21)=0.454, p=0.64; Fig. 2D). Kidney function was assessed indirectly via 260 
plasma creatinine levels. Subjects with chronic kidney disease often display increased circulating RBP4 (Kocełak et 261 
al., 2018; Xun et al., 2018). We saw no differences in plasma creatinine levels between young and aged rats 262 
(t(22)=1.133, p=0.27; FIG. 2E). However, we found significantly lower plasma creatinine in AI group compared with 263 
young and AU rats (F(2,21)=8.59, p=0.002; Y vs. AI, p=0.0116; AU vs AI, p=0.002; FIG. 2F). These data taken together 264 
indicate that the RBP4 results in aged rats are not a secondary consequence metabolic disease. 265 
 266 




Hippocampal STRA6 receptor expression is reduced in aged animals 268 
STRA6 is a cell surface receptor by which retinol enters the cell. We measured protein expression of this RA receptor 269 
in whole hippocampus from young and aged animals. Levels of STRA6 were significantly lower in aged animals 270 
compared with young (t(22)=6.00, p<0.0001; FIG. 3B). This was true for aged rats without and with spatial memory 271 
impairment (F(2,21)=17.40, p<0.0001; Y vs. AU p<0.0001; Y vs. AI, p=0.0002; FIG. 3C). Moreover, hippocampal STRA6 272 
protein levels did not differ between the aged subgroups (FIG. 3C) or correlate with memory performance (young 273 
and aged: n=24, r2=0.0.121, p=0.096; aged only: n=16, r2=0.010 p=0.148). These results indicate that, independent 274 
of cognitive outcome, hippocampal aging is associated with a reduction of the receptor allowing retinol cell entry. 275 
 276 
 277 
RA synthesis is increased in aged impaired rats 278 
The last step of RA metabolism is catalyzed by the RALDH enzymes. Here we assessed the protein expression of two 279 
RALDH enzymes in whole hippocampal preparations, RALDH1 and RALDH3. Significantly higher levels of RALDH1 280 
protein were found in aged rats relative to Y (t(22)=2.805, p=0.011; FIG. 3D). This was the case only for AI, in which 281 
hippocampal RALDH1 expression was significantly higher than in both Y and AU animals.  (F(2,20)=9.314, p=0.001; Y 282 
vs. AI p=0.001; AU vs. AI p=0.026; FIG. 3E). Notably, the expression of this enzyme correlated with LI scores among 283 
the aged animals such that rats with higher RALDH1 expression scored more poorly (i.e., higher LI scores; n=16, 284 
r2=0.42, p=0.007; FIG. 3F, black line). The correlation was similar when the young and aged animals are considered 285 
together (n=23, r2=0.518, p=0.0001; FIG. 3F, grey line). RALDH3 protein expression in whole hippocampus was 286 
comparable in the young and aged groups (t(22)=1.593, p=0.125; FIG. 3G) and unrelated to cognitive status 287 
(F(2,21)=1.22, p=0.315; FIG. 3H). In the aggregate, the results indicate that RALDH1 driven RA synthesis is potentially 288 
increased in the hippocampus of aged impaired rats.  289 
 290 
 291 
Aged impaired animals display increased RA catabolism 292 
RA is catabolized by the family of cytochrome p450 enzymes, CYP26. We measured the protein expression of 293 
CYP26A1 and CYP26B1 enzymes in the whole hippocampus preparations. CYP26A1 protein expression was largely 294 
overlapping between young and aged rats (t(22)=1.609, p=0.122; FIG. 4B) without and with spatial memory deficits 295 
(F(2,21)=1.651, p=0.216; FIG. 4C). In contrast, we detected significantly higher CYP26B1 protein expression in the aged 296 
hippocampus (t(22)=2.428, p=0.024; FIG. 4D). Interestingly, CYP26B1 levels were selectively increased in AI, differing 297 
from both young and AU rats (F(2,21)=10.85, p=0.0006; Y vs. AI p=0.0007; AU vs. AI p=0.005; FIG. 4E); levels in the 298 
latter groups were equivalent. Furthermore, there was a strong correlation between the expression of CYP26B1 and 299 
cognitive performance in the young and aged rats (n=24, r2=0.455, p=0.0003; FIG. 4F, grey line), which was also 300 
robust among the aged animals alone (n=16, r2=0.265, p=0.040; FIG. 4F, black line), such that poor spatial memory 301 
was coupled with higher CYP26B1 enzyme levels. These results suggest that, although age-related increases in RA 302 
catabolism are selectively observed in aged animals with memory impairment, catabolic enzyme levels are coupled 303 
with spatial memory across the full range of individual differences observed in both young and aged rats.  304 
 305 
 306 
Cellular and synaptosome RARα expression is increased in aged impaired rats 307 
RARα is one of six RA receptors but the only one that regulates homeostatic plasticity via non-nuclear action (Aoto 308 
et al., 2008; Yang et al., 2015). This receptor is involved in homeostatic synaptic scaling through its interaction with 309 
FMRP and GluR1. We measured RARα protein expression in whole hippocampus homogenates and found no 310 
differences in RARα expression between young and aged animals (t(22)=1.321, p=0.2; FIG. 5B). Interestingly, 311 
however, the expression of RARα was significantly elevated in AI animals in comparison with both young and AU rats 312 
   
 
 9 
(F(2,21)=6.218, p=0.008; Y vs. AI p=0.021, AU vs. AI p=0.013; FIG. 5C). In addition, cognitive scores correlated with the 313 
expression of RARα protein across the young and aged rats (n=24, r2=0.184, p=0.037; FIG. 5D, grey line), such that 314 
animals with worse spatial memory showed higher RARα expression. Among the aged animals alone, water maze 315 
performance failed to correlate significantly with RARα protein expression (n=16, r2=0.155, p=0.131; FIG. 5D, black 316 
line). The strength of the association was nearly identical in both analyses, however, suggesting that the ‘aged only’ 317 
result is less robust due to the decreased sample size and statistical power. 318 
 319 
Non-genomic actions of RA signaling are mediated by RA receptors localized outside of the nucleus. We were 320 
specifically interested in the presence of RARα in the synaptosome preparations, because non-nuclear RARα acts as 321 
a mRNA granule containing GluR1 receptor mRNA. Therefore, we measured RARα protein levels in whole 322 
hippocampus synaptosome fractions. Similar to results for the whole cell lysates, we found no differences in RARα 323 
protein presence (t(18)=1.385, p=0.18 FIG. 5E). However, AI animals displayed increased synaptosome RARα content 324 
relative to young and AU rats (F(2,17)=6.561, p=0.008; Y vs. AI p=0.026, AU vs. AI p=0.014; FIG. 5F), also similar to the 325 
pattern in whole lysates. Additionally, synaptosome RA receptor expression positively correlated with spatial 326 
memory performance among the young and aged rats, with higher LI scores (i.e., poor memory) associated with 327 
increased RARα protein expression (n=20, r2=0.312, p=0.011; FIG. 5G, grey line). A similar positive correlation was 328 
also observed when the aged animals were considered alone in the analysis (n=15, r2=0.314, p=0.030; FIG. 5G, black 329 
line). These results indicate that RARα expression is increased selectively in aged animals with memory impairment 330 
in both whole cell and synaptosome preparations. Among the aged rats, levels of this receptor localized to the 331 
synaptosome compartment were coupled with individual differences in the hippocampal memory.  332 
 333 
 334 
Hippocampal FMRP protein is increased in aged animals 335 
Next, we examined FMRP protein expression, which is required for the translation of GluR1 mRNA. We found 336 
significantly increased levels of FMRP protein in the aged hippocampus (t(22)=3.27, p=0.0035 FIG. 6B). AI values were 337 
elevated relative to young rats (F(2,21)=7.202, p=0.004; Y vs. AI p=0.003; FIG. 6C), whereas results for AU were 338 
intermediate and failed to differ from either Y or AI (FIG. 6C). FMRP protein levels failed to correlate with LI scores, 339 
and overall, the data point to a general age-related increase in hippocampal FMRP. 340 
 341 
 342 
Cellular and synaptosome GluR1 levels are increased in aged animals with memory impairment 343 
In the presence of FMRP, GluR1 mRNA is translated locally in a RARα regulated manner, enhancing AMPA receptor 344 
synaptic expression and strength. We measured GluR1 receptor protein levels in whole cell lysates and associated 345 
synaptosome preparations. No differences were observed in GluR1 expression between the young and aged group 346 
(t(22)=0.776, p=0.446; FIG. 6D). However, GluR1 protein was significantly increased in AI animals compared with AU 347 
(F(2,21)=4.161, p=0.030, AU vs. AI p=0.031; FIG. 6E), although neither aged subgroup differed from Y. The correlation 348 
between GluR1 protein levels and spatial memory was not significant when the young and aged animals were 349 
considered together (n=24, r2=0.061, p=0.245 FIG. 6F, grey line). However, a reliable correlation was observed 350 
among the aged animals (n=16, r2=0.248, p=0.050; FIG. 6F, black line), where poor spatial memory (i.e., high LI 351 
scores) was associated with higher hippocampal GluR1 levels. 352 
 353 
In the synaptosome fraction we found higher GluR1 protein expression in the aged rats than young (t(18)=3.104, 354 
p=0.006; FIG. 6G), and this effect appeared largely attributable to elevation among AI animals (F(2,17)=5.865, 355 
p=0.012; Y vs. AI p=0.009; FIG. 6H). Although we found no direct correlation between spatial memory performance 356 
and synaptosome GluR1 levels, the results suggest that ionotropic glutamate expression in hippocampus, in both 357 
the cytosol and synaptosome, is predominantly increased in AI rats. 358 





Research on the neurobiology of cognitive aging has traditionally focused on identifying differences between groups 361 
configured on the basis of chronological age. This approach, however, can obscure the increased individual 362 
variability that is a hallmark of aging in humans and animal models. Here, adopting a strategy validated in many 363 
previous studies (McQuail et al., 2018; Rapp et al., 1987, 2020), we explicitly capitalized on this variability to test 364 
whether changes in RA signaling are associated with differential cognitive outcomes in aging. The current evidence 365 
clearly documents that RA signaling in the hippocampus is disrupted across multiple levels of regulation in aged rats 366 
with memory deficits. Specifically, while levels of a key transporter of the substrate for RA (STRA6) were decreased 367 
in the aged hippocampus independent of cognitive status, changes in other components of the RA signaling 368 
pathway, including but not limited to synthesis and catabolism of RA (RALDH1, CYP26B1, RARα, FMRP and GluR1), 369 
were selectively increased among aged animals with memory impairment. Levels of most of the affected RA 370 
signaling factors were reliably correlated with individual differences in spatial memory among aged rats. Although 371 
the specific mechanisms linking changes in RA signaling to disrupted memory-related plasticity remain to be 372 
determined, in the aggregate our results point to an overall increase in hippocampal RA signaling associated with 373 
age-related cognitive impairment. While previous studies have suggested that global RA decline leads to cognitive 374 
impairment (Etchamendy et al., 2001; Bonnet et al., 2008; Dumetz et al., 2020), our findings suggest that locally 375 
increased RA signaling is coupled with age-related cognitive decline, perhaps reflecting failed compensatory 376 
mechanisms. Alongside experimental design factors that might contribute to apparent discrepancies across studies, 377 
such as rat strain and diet, the current results highlight the importance of considering RA signaling in relation to 378 
individual variability in the cognitive outcome of aging. Nonetheless, a priority knowledge gap for future 379 
investigation is to explore the direction of causality, testing whether the observed effects of aging on RA signaling 380 
are a driver of, or response to, cognitive decline.  381 
 382 
 383 
Retinol availability in aged animals 384 
The availability of retinol in the circulation is essential for the synthesis of RA. Circulating levels of retinol are 385 
dependent on dietary availability of vitamin A and are influenced by retinol storage in the liver, which is the largest 386 
storage site in the body (Napoli, 2012). The major pathway for retinol transport is through binding to RBP4/TTR 387 
complex (Li et al., 2014), and here we used plasma RBP4 levels as a proxy for retinol content in the circulation. 388 
Animals in this study were maintained under identical conditions, ensuring that dietary retinol availability was 389 
constant and not the basis of the RBP4 differences seen between the aged groups.  390 
 391 
Our results revealed significantly lower RBP4 plasma levels in AU animals compared with young. This is consistent 392 
with recent findings in humans showing decreased plasma RBP4 content in aged individuals (Soo Lee et al., 2013; 393 
Kocełak et al., 2018). Interestingly, AI animals had RBP4 levels comparable to young and significantly higher than AU 394 
rats. The liver and kidney prominently influence RBP4, because of their role in synthesis and excretion, respectively. 395 
Plasma triglyceride levels, which are indicative of liver function, were comparable across groups, suggesting that 396 
impaired liver function is unlikely to drive changes in RBP4. Renal function also affects circulating RBP4 and can be 397 
assessed by plasma creatinine levels, where high levels are indicative of kidney disease. Kocełak et al. (2018) found 398 
increased circulating RBP4 in patients with chronic kidney disease. That study concluded that plasma levels of this 399 
retinol binding protein predominantly reflect poor kidney function and are only modestly sensitive to aging. Here we 400 
found no age-related change in this binding protein. Overall, plasma RBP4 in aged animals strongly correlated with 401 
learning index scores, where low levels were detected in AU plasma. Together, this pattern of results raises the 402 
possibility that the selective decrease of plasma RBP4 seen in AU rats may be a component of an adaptive cascade, 403 
reducing retinol availability in blood, and providing a potential biomarker of resilient cognitive aging. 404 




Some studies have reported an increase in RBP4 with obesity and insulin resistance (Esteve et al., 2009; Shajarian et 406 
al., 2015), whereas others have found no relationship (Ülgen et al., 2010; Kocełak et al., 2018). Aged rats in the 407 
present experiment did not display visible signs indicative of disrupted glucose regulation (e.g., increased water 408 
consumption and urination, or sharp weight gain), confirmed by normative circulating glucose levels. Additionally, 409 
plasma triglyceride content, a core component of the metabolic syndrome, was similar between groups. Creatinine 410 
levels further suggested that the rats were free of underlying renal disease that might influence RBP4 levels. 411 
Although the aged animals were significantly heavier and exhibited greater adiposity than young, RBP4 levels were 412 
unrelated to body weight. Therefore, differences in plasma RBP4 among the aged rats were not secondary to weight 413 
gain or systemic metabolism change, and instead point to a potential RA influence on cognitive aging independent 414 
of metabolic aging.  415 
 416 
 417 
Global increase of RA metabolism in aged impaired animals  418 
A significant role of RA in memory is emerging, complementing reports that, in the hippocampus, RA is involved in 419 
homeostatic synaptic scaling (Aoto et al., 2008; Sarti et al., 2012; Hsu et al., 2019). Although there is evidence that 420 
retinol signaling is altered in the aged brain (Enderlin et al., 1997; Touyarot et al., 2013), the involvement of RA in 421 
cognitive aging has received limited attention.  422 
 423 
Our findings establish that protein levels of STRA6 receptor, which plays an important role in the retinol transport 424 
across blood-tissue barriers (Kelly et al., 2016), are decreased in the aged hippocampus. In brain, expression of this 425 
receptor is regulated by the availability of vitamin A, and in tissues other than the eye, cytosolic retinol 426 
concentration is only partly regulated by STRA6 (Berry et al., 2013). In our model, age-related decline in 427 
hippocampal STRA6 expression does not appear to be a consequence of systemic change in retinol, as the results fail 428 
to parallel the observed changes in plasma RBP4 levels.  Regardless of the mechanism, which remains to be 429 
determined, the reduction in STRA6 may reduce intracellular retinol availability. This is consistent with  decreased 430 
retinoid brain levels in aged mice (Kelly et al., 2016).  431 
 432 
We also examined the abundance of RA synthesizing and catabolizing enzymes in the hippocampus. Retinal 433 
dehydrogenase enzymes are responsible for the last step of RA synthesis. In the present experiments, RALDH1 434 
expression was increased in aged animals, whereas RALDH3 levels were unchanged. Increased RALDH1 levels in the 435 
aged hippocampus contrast with reports of reduced retinol metabolism in other tissues (Etchamendy et al., 2003; 436 
Van Der Loo et al., 2004; Das et al., 2014) raising the possibility that the increase is a brain-specific response in 437 
aging. In the future it will be useful to extend the analysis to include the third RA synthesizing enzyme, RALDH2. The 438 
RA catabolic enzymes CYP26A1 and CYP26B1 are both expressed in the rat hippocampus (McCaffery and Simons, 439 
2007; Stoney et al., 2016). CYP26A1 has greater catalytic activity for RA than CYP26B1 (Topletz et al., 2012), 440 
although CYP26B1 is more widely distributed in the brain (Stoney et al., 2016) and tightly regulates RA signaling 441 
during development (Abu-Abed et al., 2002). CYP26 gene expression is dynamically regulated by dietary retinol and 442 
RA from liver and extrahepatic tissues (Ray et al., 1997; Wang et al., 2002) While liver CYP26B1 is reportedly 443 
upregulated in aged subjects (Yamamoto et al., 2002), whether brain expression changes with age is unknown. Here 444 
we found no difference in CYP26A1 between young and aged animals, whereas CYP26B1 protein levels increased 445 
with age. In line with the observed increase in synthesizing enzyme, the predicted consequence of enhanced RA 446 
presence is a net increase in CYP26B1-mediated catabolism.  447 
 448 
One of the non-genomic functions of RA is mediated by RARα, which undergoes active nuclear transport (Poon and 449 
Chen, 2008). This receptor is implicated in homeostatic synaptic scaling (Chen et al., 2014; Li et al., 2019), synaptic 450 
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transmission in somatosensory cortex (X. Yee and Chen, 2016), and normal tactile sensory processing (Park et al., 451 
2018). Here we found significantly higher levels of RARα in AI rats, in both cytosolic and synaptosome fractions from 452 
hippocampus, suggesting that non-genomic RA action is affected in these animals. The presumed consequence is 453 
greater RARα availability for RA to bind to and release GluR1 mRNA, increasing availability for translation.  454 
 455 
The translation of GluR1 mRNA critically depends on FMRP. This protein is not directly related to the RA signaling 456 
pathway, but it is an important mediator of RA’s downstream effects. An RNA-binding functional regulator, FMRP 457 
localizes to cytosolic membranes and the nucleus (Bostrom et al., 2016; Smidak et al., 2017), where it controls 458 
synaptic protein synthesis, modulating dendritic spine formation (Feng et al., 1997; Greenough et al., 2001; Weiler 459 
et al., 2004). Deficiency of FMRP leads to local protein synthesis-dependent endocytosis of GluR1 receptor 460 
(Nakamoto et al., 2007), and activation of GluRs influences dendritic FMRP localization (Antar, 2004). In contrast to 461 
previous reports (Singh et al., 2007; Smidak et al., 2017), our findings demonstrate modest but statistically reliable 462 
increases in hippocampal FMRP protein in aged rats, an effect predominantly attributable to AI rats. This increase, 463 
together with higher expression of GluR1, is positioned to potently influence excitatory neurotransmission in the 464 
hippocampus. Interestingly, pyramidal neurons in the hippocampal CA3 region of AI animals exhibit elevated firing 465 
rates (Wilson et al., 2005), and pharmacological treatments that reduce hyperactivity improve memory in both AI 466 
rats and MCI patients (Koh et al., 2009; Bakker et al., 2012). RA actions via RARα are also known to cause 467 
downscaling of synaptic inhibition by FMRP-dependent removal of synaptic GABAA receptors (Sarti et al., 2013). It is 468 
possible, that altered GluR1 expression and network disinhibition lead to disrupted excitation/inhibition balance, 469 





Compelling evidence indicates that RA function extends well beyond metabolic control and includes regulation of 475 
memory-related synaptic plasticity.  Here we demonstrate that RA signaling in neurocognitive aging is affected at 476 
nearly all levels of regulation examined. We found a decrease in plasma RBP4 in aged animals without memory 477 
impairment. Net hippocampal RA signaling is likely increased in aged rats with cognitive impairment, reflecting in 478 
part greater synthesizing and catabolizing enzyme expression. Furthermore, we find increases in RARα, FMRP and 479 
GluR1 selectively in aged rats with memory impairments. These changes appear unrelated to metabolic aging, and 480 
instead most are specifically related to individual differences in the cognitive outcome of aging rather than 481 
chronological age.  The importance of neuronal excitation/inhibition balance in relation to cognitive outcome has 482 
been highlighted in many studies and is the core of numerous neurological diseases where altered RA signaling is 483 
implicated (Wołoszynowska-Fraser et al., 2020). Together the current results lean in favor of increased RA signaling, 484 
potentially contributing to the excitation/inhibition imbalance that is prominently featured in age-related cognitive 485 
impairment. This work further extends the boundaries of RA function in brain, and specifically highlights the 486 
importance of considering aging effects in relation to individual variability in cognitive aging. Among potential future 487 
directions, a comprehensive account of RA signaling influences on neurocognitive aging will also require a parallel 488 
assessment of genomic pathway effects. 489 
 490 
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Figure 1 Spatial memory performance, animal weight and plasma RBP4 levels  690 
Learning index scores for individual young and aged animals (A); plasma RBP4 levels presented as % of young baseline (B and C); 691 
correlation of plasma RBP4 and LI score (D); mean body weights of animals tested. Note that body weight did not differ among 692 
the aged rats (E and F); correlation of plasma RBP4 and body weight (G). Results shown as bars with individual animal data 693 
plotted. Statistical analysis – unpaired 2-tailed Student’s t-test (B, E and F), one-way ANOVA, with Tukey’s multiple comparisons 694 
test (C), and linear regression (D and G; all animals – grey line; aged animals – black line); ** p<0.01; *** p<0.001. Young n=16 695 
and aged n=32 (AU n=15, AI n=17; panel A); young n=8 and aged n=16 (AU n=8, AI n=8; panels B-G).  Error bars represent 696 
standard error of mean. 697 




















































   



















































   






































Figure 2 Plasma glucose, triglyceride and creatinine levels  701 
Levels of plasma glucose (A and B) triglyceride (C and D), and creatinine (E and F) in the Y, aged, AU, and AI groups. Results shown 702 
as bars with individual animal data plotted. Statistical analysis – unpaired 2-tailed Student’s t-test (A, C and E), and one-way 703 
ANOVA, with Tukey’s multiple comparisons test (B, D and F); * p<0.05; ** p<0.01. Young n=8 and aged n=16 (AU n=8, AI n=8; all 704 








Figure 3 Protein expression of STRA6, RALDH1 and RALDH3 in the hippocampus  710 
Representative blots for proteins of interest (A), expression relative to b-actin as a percentage of young values, L stands for 711 
molecular ladder lane. Hippocampal expression of STRA6 (B and C), RALDH1 (D and E) and RALDH3 (G and H). Correlation of 712 
protein expression of RALDH1 and LI scores (F). Results shown as bars with individual animal data plotted. Statistical analysis – 713 
unpaired 2-tailed Student’s t-test (B, D and G), one-way ANOVA, with Tukey’s multiple comparisons test (C, E and H), and linear 714 
regression (F; all animals – grey line; aged animals – black line); Y – young, AU – aged unimpaired, AI – aged impaired; * p<0.05; 715 
** p<0.01; *** p<0.001; **** p<0.0001. Young n=8 and aged n=16 (AU n=8, AI n=8; B, G-H); young n=7 and aged n=16 (AU n=7, 716 
AI n=9; D-F). Error bars represent standard error of mean. 717 
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Figure 4 Protein expression of RA catabolizing enzymes in the hippocampus 721 
Representative blots for proteins of interest (A), CYP26A1 expression relative to GAPDH, CYP26B1 expression relative to b-actin, L 722 
stands for molecular ladder lane. Hippocampal expression of CYP26A1 (B and C), and CYP26B1 (D and E). Correlation of CYP26B1 723 
levels and LI scores (F). Results shown as bars with individual animal data plotted. Statistical analysis – unpaired 2-tailed Student’s 724 
t-test (B and D), one-way ANOVA, with Tukey’s multiple comparisons test (C and E), and linear regression (F; all animals – grey 725 
line; aged animals – black line); Y – young, AU – aged unimpaired, AI – aged impaired; * p<0.05; ** p<0.01; *** p<0.001. Young 726 
n=8 and aged n=16 (AU n=8, AI n=8; B-F). Error bars represent standard error of mean. 727 

























    
  















































































Figure 5 Cellular and dendritic RARα expression in the hippocampus 729 
Representative blots for RARα (A), cellular RARα expression relative to b-actin (bottom two panels), and synaptosome RARα 730 
expression relative to PSD95 (top two panes); L stands for molecular ladder lane. Cytosolic fraction included as a confirmation of 731 
the fractionation. Hippocampal expression of RARα (B and C). Correlation of RARα protein levels with LI scores (D). Synaptosome 732 
compartment RARα content (E and F). Correlation of synaptosome RARα levels and LI scores (G Results shown as bars with 733 
individual animal data plotted. Statistical analysis – unpaired 2-tailed Student’s t-test (B and E), one-way ANOVA, with Tukey’s 734 
multiple comparisons test (C and F), and linear regression (D and G; all animals – grey line; aged animals – black line); Y – young, 735 
AU – aged unimpaired, AI – aged impaired; C – cytosolic fraction; * p<0.05. Young n=8 and aged n=16 (AU n=8, AI n=8; B-D); 736 
young n=5 and aged n=15 (AU n=7, AI n=8; E-G). Error bars represent standard error of mean. 737 






















































































































































Figure 6 FMRP expression and cellular and dendritic expression of GluR1 in the hippocampus  739 
Representative blots for proteins of interest (A), FMRP expression relative to GAPDH (bottom four panels); cellular GluR1 740 
expression relative to b-actin, and synaptosome GluR1 levels relative to PSD95 (top two panels); L stands for molecular ladder 741 
lane. Cytosolic fraction included as confirmation of the fractionation. Hippocampal expression of FMRP (B and C). Whole 742 
hippocampus (D and E) and synaptosome GluR1 protein levels (G and H). Correlation of cytosolic GluR1 protein expression with LI 743 
scores (F). Results shown as bars with individual animal data plotted. Statistical analysis – unpaired 2-tailed Student’s t-test (B, D 744 
and G), one-way ANOVA, with Tukey’s multiple comparisons test (C, E and H), and linear regression (F; all animals – grey line; 745 
aged animals – black line); Y – young, AU – aged unimpaired, AI – aged impaired; C – cytosolic fraction; * p<0.05. Young n=8 and 746 
aged n=16 (AU n=8, AI n=8; B-F); young n=5 and aged n=15 (AU n=7, AI n=8; G-H). Error bars represent standard error of mean. 747 
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